Biotechnology VALUE FUND II L.P., 10% Owner at Xenon Pharmaceuticals Inc. (XENE), bought 88,209 shares at $2.70 ($233K) on 2017-08-14, disclosed to the SEC on 2017-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.70 | 13,337 | $36K | 15.5% |
| 2 | $2.70 | 28,007 | $76K | 32.5% |
| 3 | $2.70 | 28,007 | $76K | 32.5% |
| 4 | $2.41 | 7,429 | $18K | 7.7% |
| 5 | $2.41 | 11,429 | $28K | 11.8% |
| Total | $2.64 avg | 88,209 |
| $233K |
| 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |